{{Rsnum
|rsid=9895585
|Gene=PYY
|Chromosome=17
|position=43987619
|Orientation=plus
|GMAF=0.1203
|Gene_s=PYY
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 92.9 | 7.1 | 0.0
| HCB | 77.4 | 21.2 | 1.5
| JPT | 74.3 | 23.9 | 1.8
| YRI | 46.3 | 43.5 | 10.2
| ASW | 71.9 | 22.8 | 5.3
| CHB | 77.4 | 21.2 | 1.5
| CHD | 73.4 | 25.7 | 0.9
| GIH | 82.2 | 17.8 | 0.0
| LWK | 46.8 | 44.0 | 9.2
| MEX | 84.5 | 15.5 | 0.0
| MKK | 59.0 | 35.3 | 5.8
| TSI | 90.2 | 7.8 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Illumina Human 1M}}